Apple Watch Series has stated that the Apple Watch Series 9 and Apple Watch 2 Ultra smartwatches will no longer be sold in the United States.
Apple Watch Series 9 and Watch Ultra 2 Will Not Be Available For Sale in the US
On September 12, Apple released the Apple Watch Series 9 and Apple Watch Ultra 2 smartwatches worldwide. The smartwatches were introduced at the same time as the iPhone 15 series handsets. According to 9to5Mac, Apple’s flagship Series 9 and Ultra 2 smartwatches will no longer be sold in the United States.
Apple will soon stop selling the flagship Apple Watch Series 9 and Apple Watch Ultra 2 smartwatches.
The Internal Trade Commission, also known as the ITC in the United States, has found that Apple infringed on Masimo’s patents. The ITC decision concerns the technology used to measure blood oxygen levels. Apple confirms that the Apple Watch Series 9 and Apple Watch Ultra 2 will not be available for purchase through Apple’s online store beginning at 3 p.m. (ET) on December 21.
In-store purchases of the product will be discontinued on December 24 in all Apple retail shops in the United States. Joe Biden, President of the United States, has yet to review the ITC verdict. The administration can either veto the ruling or accept the ITC’s decision. The ITC verdict upholds the decision made against Apple in January.
The deadline for reviewing the ITC ruling issued by Joe Biden’s administration is December 25. The ITC’s final decision will not be revealed until after Christmas in the United States. To ensure a smooth exit from the US markets, the Cupertino behemoth has prematurely announced the decision to withdraw its smartwatches from the market.
Apple confirmed that the Apple Watch SE will not be pulled from US markets. The Cupertino company has not provided the Watch SE with the capacity to read blood oxygen levels. The ITC order does not preclude merchants from selling Apple Watch Series 9 and Apple Watch Ultra 2 smartwatches beginning on the above-mentioned dates.
Nevertheless, Apple would not be permitted to sell its flagship smartwatches to stores in the country. The ITC order effectively prevents Apple from importing the devices and selling them throughout the country. In a 2020 lawsuit, Masimo accused Apple of obtaining information skills and recruiting Masimo’s employees to join the Cupertino firm.
In 2013, the Cupertino behemoth approached Masimo about a possible collaboration to create technology for measuring blood oxygen levels. For the first time, Apple introduced the Series Watch 6 with the ability to measure blood oxygen levels. Since then, Apple has integrated the capability for reading blood oxygen levels in all smartwatches except the SE series.
The ITC issued its decision in October, upholding the January judgment with a sixty-day administrative review. Masimo believes that the Cupertino behemoth has committed over 100 patent infringements. Economic analysts in the United States believe that the Biden administration will not veto the ITC verdict.
According to analysts, Apple Watches have no economic impact when compared to iPhones. If the government upholds the ITC verdict, Apple might lose billions of dollars in wearables income. Apple defended the Masimo case in ITC as a brand PR exercise before the launch of Masimo smartwatches.